NCT02237807View on ClinicalTrials.gov

Semi-replicate Crossover Bioequivalence Study of Dirithromycin in Healthy Subjects Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Healthy
Interventions
DRUG

DIRITHROMYCIN 500 MG ENTERIC COATED TABLET

DRUG

DYNABAC 250 MG ENTERIC COATED TABLET

Trial Locations (1)

11941

Arab Pharmaceutical industry Consulting/ Pharmaceutical Research Unit, Amman

Sponsors
All Listed Sponsors
collaborator

Abdi Ibrahim Ilac San. ve Tic A.S.

INDUSTRY

lead

Pharmaceutical Research Unit, Jordan

OTHER